Navigation Links
Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies
Date:6/8/2009

SAN DIEGO, June 8 /PRNewswire-FirstCall/ -- Dr. Steven Josephs, Ph.D., a former National Cancer Institute (NCI) researcher, has joined Entest BioMedical Inc.'s (www.entestbio.com) Science Advisory Board where he will focus on expanding the company's stem cell cancer research. Dr. Josephs' NCI research involved studies of the human T-cell leukemia virus, HIV and Human Herpervirus-6 genetic characterization. Josephs also worked for Baxter Healthcare and GenStar Therapeutics where he focused on the cellular and molecular biology of gene therapy for hemophilia. Entest BioMedical Inc. is a wholly-owned subsidiary of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN; www.BMSN.us).

According to David Koos, Chairman and CEO of both Entest BioMedical Inc. and Bio-Matrix Scientific Group Inc., "Dr. Josephs' extensive cancer research background adds strength to our growing Scientific Advisory Board. His insight into potential stem cell therapies for cancer patients will help expedite Entest BioMedical's goal of providing innovative stem cell transplantation therapies and services including autologous and allogenic peripheral blood or bone marrow transplantation.

Dr. Feng Lin, Director of Research for Entest BioMedical and Bio-Matrix Scientific Group, also applauded the addition of Dr. Josephs' to the Science Advisory Board. "Dr. Josephs joins our life science team at exactly the right time," said Lin. "We're currently interested in differentiating hematopoietic stem cells into immune cells especially T-cells. Dr. Josephs will work with us on our research goal of generating a new population of immune cells from a patient's own stem cells to reactivate the patient's immune system. This strategy represents a novel and effective immunotherapy especially for cancer patients and HIV patients who have injured immune systems and are at high risk of infection with bacteria and viruses."

About Entest BioMedical Inc.:

Entest BioMedical, Inc., a wholly-owned subsidiary of Bio-Matrix Scientific Group, Inc. (OTC BB: BMSN) formed in April 2009, focuses on research and development of traumatic brain injury (TBI) and spinal cord injury using autologous 'adipose-derived' stem cells. Entest BioMedical is involved with R&D activities relating to stem cell therapies, diabetes testing and medical devices.

About Bio-Matrix Scientific Group Inc.:

Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) is a San Diego, California based biotechnology research and development company with a 15,000 square foot facility that houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology and flow cytometry laboratories.

Disclaimer:

This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.


'/>"/>
SOURCE Bio-Matrix Scientific Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
2. New Video Series Spotlights Role of Biomedical Engineers in Caring for Total Artificial Heart Patients
3. Response Biomedical Closes $12.65 million Unit Offering
4. Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenners New Face
5. Response Biomedical Announces Proposed Unit Offering
6. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
7. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
8. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
9. Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards
10. Response Biomedical Corporation Reports 2008 Financial Results
11. Advance Internet Launches HireBioMedical.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... June 24, 2016 Research ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural Health ... Structural electronics involves electronic and/or electrical ... structures, replacing dumb structures such as vehicle bodies ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology: